HHS Public Access Author manuscript Author Manuscript
Nutr Res. Author manuscript; available in PMC 2017 March 24. Published in final edited form as: Nutr Res. 2016 January ; 36(1): 65–71. doi:10.1016/j.nutres.2015.11.006.
Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not: The TRIUMPH Study WS Harrisa, KF Kennedyb, TM Maddoxc, S Kuttyd, and JA Spertusb,e aSanford
Author Manuscript
School of Medicine, University of South Dakota and Omegaquant Analytics, LLC. 5009 W. 12th St, Ste 8, Sioux Falls, SD, USA. [email protected]
bMid
America Heart Institute, 4320 Wornall Road, Kansas City, MO, USA. [email protected]
cVA
Eastern Colorado Health Care System, University of Colorado School of Medicine, Denver, CO, USA. [email protected] dDepartments
of Cardiology and Pediatric Cardiology, University of Nebraska Medical Center, Omaha, NE, USA. [email protected]
eUniversity
of Missouri-Kansas City, Kansas City, MO, USA. [email protected]
Abstract Author Manuscript Author Manuscript
The utility of fish oil supplements (FOS) in patients who survive an acute myocardial infarction (MI) remains controversial, with randomized trials showing less benefit than observational studies would suggest. The differences in the characteristics of MI patients who use FOS in routine clinical care are unknown, but may help explain this discrepancy. We utilized data from a 24-site registry study in which extensive information was available on 4340 MI patients at admission and 1, 6, and 12 months post discharge. After excluding those using FOS at admission (n=651), who died before the 1-month follow-up visit (n=63), and those with missing data at 1 month (n=1228), 2398 remained. Of them 377 (16%) started FOS within 1 month of their MI. We analyzed 53 patient characteristics associated with FOS use. We observed differences (p
Nutr Res. Author manuscript; available in PMC 2017 March 24. Published in final edited form as: Nutr Res. 2016 January ; 36(1): 65–71. doi:10.1016/j.nutres.2015.11.006.
Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not: The TRIUMPH Study WS Harrisa, KF Kennedyb, TM Maddoxc, S Kuttyd, and JA Spertusb,e aSanford
Author Manuscript
School of Medicine, University of South Dakota and Omegaquant Analytics, LLC. 5009 W. 12th St, Ste 8, Sioux Falls, SD, USA. [email protected]
bMid
America Heart Institute, 4320 Wornall Road, Kansas City, MO, USA. [email protected]
cVA
Eastern Colorado Health Care System, University of Colorado School of Medicine, Denver, CO, USA. [email protected] dDepartments
of Cardiology and Pediatric Cardiology, University of Nebraska Medical Center, Omaha, NE, USA. [email protected]
eUniversity
of Missouri-Kansas City, Kansas City, MO, USA. [email protected]
Abstract Author Manuscript Author Manuscript
The utility of fish oil supplements (FOS) in patients who survive an acute myocardial infarction (MI) remains controversial, with randomized trials showing less benefit than observational studies would suggest. The differences in the characteristics of MI patients who use FOS in routine clinical care are unknown, but may help explain this discrepancy. We utilized data from a 24-site registry study in which extensive information was available on 4340 MI patients at admission and 1, 6, and 12 months post discharge. After excluding those using FOS at admission (n=651), who died before the 1-month follow-up visit (n=63), and those with missing data at 1 month (n=1228), 2398 remained. Of them 377 (16%) started FOS within 1 month of their MI. We analyzed 53 patient characteristics associated with FOS use. We observed differences (p
